Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (ABRYSVO) | PFIZER\WYETH | N/A | — | IM / UN |
Patient received two doses of abrysvo vaccine without any medical consequence or effect that was life threatening or other medical concern leading to immediate medical attention or further medical review. ACIP (Advisory Committee on Immunization Practices (ACIP) guidelines did not specify harmful outcome related to duplicate dose of abrysvo.
None specified by patient
DM, HTN, Spondylosis, urinary incontinence, chronic pain, gastrointestinal disease, respiratory system disorder, peripheral neuropathy
None specified by patient
NKDA
none recommended